See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 23, 2010

Alzheimer's Disease (Ages 50-89) Ovarian Cancer Influenza

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Alzheimer's Disease (Ages 50-89)

This is a phase III clinical trial to evaluate an investigational treatment for mild-to-moderate Alzheimer's disease.

The research site is in Las Vegas, Nev.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/alzheimer's_disease.aspx.

-----

Ovarian Cancer

This clinical research study is investigating whether an investigational drug is safe and effective when given in combination with carboplatin and taxane for women who have platinum-sensitive epithelial ovarian cancer that relapsed between 6 and 24 months after first-line treatment with a platinum-containing chemotherapy regimen.

The research site is in Hackensack, N.J.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/ovarian_cancer.aspx.

-----

Influenza

This study is for people who believe they have the flu. To qualify, you must have flu-like symptoms that began in the past 48 hours.

The research site is in Council Bluffs, Ia.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/influenza.aspx.

-----

Copyright 2010 ClinicalConnection.com. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.